ArticleThoracic cancer2020

Patterns of response in metastatic NSCLC during PD-1 or PD-L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria.

Hongge Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.